Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
13.18
+0.79 (6.38%)
At close: Oct 27, 2026, 4:00 PM EDT
13.44
+0.26 (1.97%)
After-hours: Oct 27, 2026, 7:59 PM EDT
Mesoblast Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Mesoblast stock has a consensus rating of "Buy" and an average price target of $37. The average 1-year stock price forecast is 180.73% higher than the current stock price, while the lowest is $35 (+165.55%) and the highest is $39 (+195.90%).
Price Target: $37 (+180.73%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 25, 2026.
Analyst Ratings
The average analyst rating for Mesoblast stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +165.55% | Sep 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $35 → $39 | Buy | Reiterates | $35 → $39 | +195.90% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
182.61M
from 120.25M
Increased by 51.86%
Revenue Next Year
298.27M
from 182.61M
Increased by 63.33%
EPS This Year
-0.02
from -0.04
EPS Next Year
0.07
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers.